The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia

Blood. 2021 Sep 16;138(11):992-996. doi: 10.1182/blood.2021012479.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • COVID-19 / prevention & control*
  • ChAdOx1 nCoV-19 / adverse effects*
  • Cohort Studies
  • Female
  • Humans
  • Immunoglobulins, Intravenous / administration & dosage
  • Immunoglobulins, Intravenous / therapeutic use*
  • Male
  • Middle Aged
  • Platelet Count
  • Purpura, Thrombocytopenic, Idiopathic / etiology*
  • Purpura, Thrombocytopenic, Idiopathic / therapy*
  • Young Adult

Substances

  • Immunoglobulins, Intravenous
  • ChAdOx1 nCoV-19